Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Mark Brosius sold 46 shares of the stock in a transaction on Friday, November 20th. The shares were sold at an average price of $407.24, for a total value of $18,733.04. Following the sale, the executive vice president owned 227 shares of the company’s stock, valued at $92,443.48. This trade represents a 16.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Brosius also recently made the following trade(s):
- On Wednesday, November 18th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The shares were sold at an average price of $430.63, for a total value of $19,808.98.
- On Monday, November 16th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The shares were sold at an average price of $444.38, for a total value of $20,441.48.
- On Wednesday, October 28th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The stock was sold at an average price of $441.60, for a total value of $26,937.60.
- On Monday, October 26th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The stock was sold at an average price of $451.75, for a total value of $27,556.75.
- On Friday, September 11th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The stock was sold at an average price of $365.79, for a total transaction of $9,144.75.
- On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $350.20, for a total transaction of $8,054.60.
- On Tuesday, September 8th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $361.23, for a total transaction of $16,616.58.
Intuitive Surgical Stock Down 2.0%
Shares of Intuitive Surgical stock traded down $8.18 on Friday, hitting $399.06. 2,689,871 shares of the company traded hands, compared to its average volume of 2,435,572. The company has a 50-day moving average price of $423.51 and a 200 day moving average price of $427.91. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The company has a market cap of $138.33 billion, a PE ratio of 48.25, a PEG ratio of 2.90 and a beta of 1.45.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company’s revenue was up 21.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.40 earnings per share. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.
Hedge Funds Weigh In On Intuitive Surgical
Several hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE boosted its holdings in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after buying an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $1,335,753,000. Amundi grew its position in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership increased its position in shares of Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after acquiring an additional 1,027,475 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its holdings in Intuitive Surgical by 10.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock worth $769,948,000 after purchasing an additional 184,044 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have commented on the company. Oppenheimer reiterated an “outperform” rating and issued a $500.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. HSBC cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective on the stock. in a research note on Thursday, July 30th. Wells Fargo & Company reissued an “overweight” rating and issued a $486.00 price objective (down from $487.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Thursday, November 12th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $495.90.
Read Our Latest Report on ISRG
Trending Headlines about Intuitive Surgical
Here are a few of the latest headlines about ISRG:
- Positive Sentiment: A BTIG Research analyst reportedly expects ISRG shares to rise, providing a positive analyst signal; the headline does not specify a price target or the reasoning. BTIG analyst article
- Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article
- Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article
About Intuitive Surgical
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
